354548-73-5 Usage
Uses
Used in Pharmaceutical Industry:
3-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, 3-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid serves as a building block for the creation of novel agrochemicals, contributing to the development of more effective and targeted pest control solutions.
Used in Drug Development:
3-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid is utilized as a starting material in the design and synthesis of new drug candidates. Its potential biological activities are being studied to identify its therapeutic potential in various disease conditions.
Used as a Tool Compound in Biochemical Research:
Due to its unique structure and reactivity, 3-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid has shown promise as a tool compound for studying various biochemical processes. It aids researchers in understanding the mechanisms of action and interactions of different biomolecules, contributing to the advancement of scientific knowledge in the field.
Check Digit Verification of cas no
The CAS Registry Mumber 354548-73-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,4,5,4 and 8 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 354548-73:
(8*3)+(7*5)+(6*4)+(5*5)+(4*4)+(3*8)+(2*7)+(1*3)=165
165 % 10 = 5
So 354548-73-5 is a valid CAS Registry Number.
InChI:InChI=1/C8H5BrN2O2/c9-7-6(8(12)13)10-5-3-1-2-4-11(5)7/h1-4H,(H,12,13)
354548-73-5Relevant academic research and scientific papers
Identification of fused bicyclic heterocycles as potent and selective 5-HT2A receptor antagonists for the treatment of insomnia
Xiong, Yifeng,Ullman, Brett,Choi, Jin-Sun Karoline,Cherrier, Martin,Strah-Pleynet, Sonja,Decaire, Marc,Feichtinger, Konrad,Frazer, John M.,Yoon, Woo H.,Whelan, Kevin,Sanabria, Erin K.,Grottick, Andrew J.,Al-Shamma, Hussien,Semple, Graeme
scheme or table, p. 1870 - 1873 (2012/04/17)
A series of fused bicyclic heterocycles was identified as potent and selective 5-HT2A receptor antagonists. Optimization of the series resulted in compounds that had improved PK properties, favorable CNS partitioning, good pharmacokinetic properties, and significant improvements on deep sleep (delta power) and sleep consolidation.
